PMA device
Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart Valve
Corcym S.r.l. · Heart-Valve, Non-Allograft Tissue (LWR, Class III) · First FDA decision Jan 8, 2016, newest Mar 12, 2025Aortic stenosisMitral regurgitationTricuspid regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
7
Naming "Perceval Sutureless"
MAUDE reports
1,581
Brand "Perceval Sutureless", since 2015
PubMed studies
137
Mentioning "Perceval Sutureless"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart Valve
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
P150011-S028 · Decided Mar 12, 2025 · 237 days after receipt · Normal 180 Day Track No User Fee
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
P150011-S030 · Decided Jan 24, 2025 · 85 days after receipt · Normal 180 Day Track
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
- Perceval Sutureless Heart ValvePMA supplement
P150011-S013 · Decided Oct 16, 2020 · 899 days after receipt · Normal 180 Day Track
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Perceval Sutureless", any status and sponsor, newest update first.
- Perceval Sutureless Implant Versus Standard-Aortic Valve ReplacementPivotal-lookingTerminated
Corcym S.r.lNot on our public-company list
NCT02673697 · 914 participants · Start Mar 22, 2016 · Primary completion Jan 17, 2020
Device: Perceval valve; other stented biological valve · For: Aortic Valve Disease; Aortic Stenosis
Sites: Indianapolis, Indiana; Portland, Maine; Cleveland, Ohio · 47 sites in all
- Clinical Data Collection on Perceval S Sutureless Prosthetic Aortic Valve in the Chinese PopulationStatus unknown
Corcym S.r.lNot on our public-company list
NCT06011148 · 80 participants (planned) · Start Dec 2024 · Primary completion Dec 2025
Device: Perceval S sutureless heart valve · For: Aortic Valve Disease
Corcym S.r.lNot on our public-company list
NCT01368666 · 658 participants · Start Feb 23, 2010 · Primary completion Oct 31, 2014
Device: Perceval S Valve Prosthesis · For: Aortic Valve Replacement
Sites: Graz, Austria; Vienna, Austria; Aalst, Belgium · 26 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Perceval Sutureless", and for the whole product code for context.
This brand
1,581 reports: 34 malfunction, 1,399 injury, 143 death
Whole product code LWR
17,256 reports: 871 malfunction, 15,439 injury, 934 death
Newest reports for this brand
3004478276-2026-00178 · Received Oct 19, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
3004478276-2026-00177 · Received Oct 16, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Off-Label Use
Patient problem as coded: Cardiogenic Shock; Cardiac Perforation
3004478276-2026-00172 · Received Oct 8, 2026 · Event dated Sep 21, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Degraded
Patient problem as coded: Aortic Valve Stenosis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0716-2017 · Started Oct 31, 2016
Reason given: Sorin Group USA, Inc. announces a voluntary field action for the Perceval Sutureless Heart Valve due to updated steps associated with the implantation procedure.
Cause as FDA categorized it: Use error · Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Published research
The most relevant PubMed records for "Perceval Sutureless"[tiab]. The summary above synthesizes these.
- The Perceval Sutureless Bioprosthetic Aortic Valve: Evolution of Surgical Valve Technology.
Fialka NM, El-Andari R, Wang S, et al. · Innovations (Phila) · 2024Review
- Perceval Sutureless Valve - are Sutureless Valves Here?
Chandola R, Teoh K, Elhenawy A, et al. · Curr Cardiol Rev · 2015Review
- Perceval Sutureless Aortic Valve Implantation: Midterm Outcomes.
Szecel D, Eurlings R, Rega F, et al. · Ann Thorac Surg · 2021
- Perceval ViV-TAVR: Perception Is Not Always Reality.
Reisinger M, James E, Kachel M, et al. · JACC Case Rep · 2024Case Reports
- TAVR to Solve Perceval Sutureless Valve Migration.
López-Tejero S, Núñez-García JC, Antúnez-Muiños P, et al. · JACC Cardiovasc Interv · 2022
- Conventional Prostheses versus Sutureless Perceval for Aortic Valve Replacement: A Meta-Analysis.
Colarossi G, Migliorini F, Becker M, et al. · Ann Thorac Cardiovasc Surg · 2023Meta-Analysis
- Thrombocytopenia Following Perceval Sutureless Aortic Valve Replacement in Asian Patients.
Nakayama T, Nakamura Y, Shikata F, et al. · Circ J · 2024
- Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the Perfecta study.
Nardi P, Altieri C, Pisano C, et al. · Kardiochir Torakochirurgia Pol · 2024
- Benefits and Pitfalls of the Perceval Sutureless Bioprosthesis.
Dokollari A, Ramlawi B, Torregrossa G, et al. · Front Cardiovasc Med · 2021Review
- The Perceval Sutureless Aortic Valve: Review of Outcomes, Complications, and Future Direction.
Powell R, Pelletier MP, Chu MWA, et al. · Innovations (Phila) · 2017Review
- Commentary: Perceval sutureless valve-one more seat at the round table of short-term follow-up.
McKellar SH · J Thorac Cardiovasc Surg · 2021Editorial, Comment
- Perceval Sutureless Valve and Structural Valve Deterioration.
Mastrobuoni S, de Kerchove L · Ann Thorac Surg · 2021Letter, Comment
Other devices of this type
Also filed under product code LWR.
- Edwards Pericardial Aortic Bioprosthesis and INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2022
- St. Jude Medical Biocor and Biocor Supra ValvesAbbott Medical · PMA 2012
- INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2026
- Mitroflow Aortic Pericardial Heart ValveCorcym Canada Corp · PMA 2019
- TRIFORMIS RESILIA Tricuspid ValveEdwards Lifesciences, LLC · PMA 2026
- Sjm Biocor Valve / Sjm Biocor Supra ValveAbbott Medical · PMA 2016
- Ats 3F Aortic Bioprosthesis Model 1000Medtronic, Inc. · PMA 2019
- Freestyle Aortic Root BioprosthesisMedtronic, Inc. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.